Laxans

Sodium picosulfate, the active ingredient in Laxans, is a stimulant laxative presented as an oral formulation for oral use. It is employed to relieve occasional constipation by stimulating colonic peristalsis and enhancing fluid secretion within the bowel, providing a short‑term, non‑habit‑forming solution for bowel irregularity.

GNH USA supplies Laxans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements. The company provides reliable logistics, documentation support, and responsive customer service to meet global procurement needs.

Sodium picosulfate acts as a stimulant laxative to facilitate bowel movements in patients with functional constipation, providing a rapid onset of action for short‑term relief. - Occasional constipation: promotes regular bowel movements in individuals experiencing infrequent stools. - Functional constipation: improves stool frequency and ease of passage in patients with chronic constipation not caused by structural disease. - Constipation associated with reduced mobility: helps restore regularity in patients with limited physical activity.

Sodium picosulfate may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps: cramping sensation in the lower abdomen. - Diarrhea: loose, watery stools. - Nausea: feeling of sickness. - Flatulence: increased gas. - Urgency: sudden need to defecate. - Thirst: increased fluid intake. - Vomiting: expulsion of stomach contents. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal sodium or potassium levels. - Severe dehydration: marked loss of body fluids. - Rectal bleeding: blood in stool. - Allergic reaction: rash, itching, swelling. - Colonic perforation: rare tear in the colon wall. - Severe abdominal pain: intense, persistent pain in the abdomen.

When using sodium picosulfate, certain precautions should be observed to minimize risks and ensure safe use. - Assess hydration status: ensure patient is adequately hydrated before treatment. - Avoid use in intestinal obstruction: contraindicated in patients with known blockage. - Use cautiously in the elderly: monitor for excessive fluid loss and electrolyte disturbances. - Do not combine with other stimulant laxatives: increased risk of severe diarrhea. - Do not use in patients with inflammatory bowel disease flare: may exacerbate symptoms. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Sodium picosulfate can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Anticholinergic agents: may reduce the laxative effect. - Opioid analgesics: can counteract colonic stimulation.

Moderate Interactions (Monitor Closely): - Antidiarrheal agents (e.g., loperamide): may diminish the intended action. - Mineral oil: may interfere with absorption of the active metabolite. - Electrolyte supplements (e.g., potassium): monitor levels due to potential electrolyte shifts.